288 related articles for article (PubMed ID: 33292474)
1. Thymidine kinase 1 through the ages: a comprehensive review.
Bitter EE; Townsend MH; Erickson R; Allen C; O'Neill KL
Cell Biosci; 2020 Nov; 10(1):138. PubMed ID: 33292474
[TBL] [Abstract][Full Text] [Related]
2. Membrane expression of thymidine kinase 1 and potential clinical relevance in lung, breast, and colorectal malignancies.
Weagel EG; Burrup W; Kovtun R; Velazquez EJ; Felsted AM; Townsend MH; Ence ZE; Suh E; Piccolo SR; Weber KS; Robison RA; O'Neill KL
Cancer Cell Int; 2018; 18():135. PubMed ID: 30214377
[TBL] [Abstract][Full Text] [Related]
3. Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker.
Wang J; Liu Q; Zhou X; He Y; Guo Q; Shi Q; Eriksson S; Zhou J; He E; Skog S
Tumour Biol; 2017 Jun; 39(6):1010428317706479. PubMed ID: 28651488
[TBL] [Abstract][Full Text] [Related]
4. Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib.
Bagegni N; Thomas S; Liu N; Luo J; Hoog J; Northfelt DW; Goetz MP; Forero A; Bergqvist M; Karen J; Neumüller M; Suh EM; Guo Z; Vij K; Sanati S; Ellis M; Ma CX
Breast Cancer Res; 2017 Nov; 19(1):123. PubMed ID: 29162134
[TBL] [Abstract][Full Text] [Related]
5. Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker.
Jagarlamudi KK; Shaw M
Biomark Med; 2018 Sep; 12(9):1035-1048. PubMed ID: 30039979
[TBL] [Abstract][Full Text] [Related]
6. Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker.
Jagarlamudi KK; Hansson LO; Eriksson S
BMC Cancer; 2015 Feb; 15():66. PubMed ID: 25881026
[TBL] [Abstract][Full Text] [Related]
7. Feline thymidine kinase 1: molecular characterization and evaluation of its serum form as a diagnostic biomarker.
Wang L; Sharif H; Saellström S; Rönnberg H; Eriksson S
BMC Vet Res; 2021 Sep; 17(1):316. PubMed ID: 34579716
[TBL] [Abstract][Full Text] [Related]
8. A new cell proliferating marker: cytosolic thymidine kinase as compared to proliferating cell nuclear antigen in patients with colorectal carcinoma.
Wu J; Mao Y; He L; Wang N; Wu C; He Q; Skog S
Anticancer Res; 2000; 20(6C):4815-20. PubMed ID: 11205225
[TBL] [Abstract][Full Text] [Related]
9. Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1.
Rausch S; Hennenlotter J; Teepe K; Kuehs U; Aufderklamm S; Bier S; Mischinger J; Gakis G; Stenzl A; Schwentner C; Todenhöfer T
Urol Oncol; 2015 Oct; 33(10):426.e21-9. PubMed ID: 26231311
[TBL] [Abstract][Full Text] [Related]
10. Comparative aspects of the proliferation marker thymidine kinase 1 in human and canine tumour diseases.
von Euler H; Eriksson S
Vet Comp Oncol; 2011 Mar; 9(1):1-15. PubMed ID: 21303450
[TBL] [Abstract][Full Text] [Related]
11. Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma.
Mattsson Ulfstedt J; Venge P; Holmgren S; Enblad G; Eriksson S; Molin D
Ups J Med Sci; 2021; 126():. PubMed ID: 34471484
[TBL] [Abstract][Full Text] [Related]
12. Serum thymidine kinase 1 levels correlate with clinical characteristics of esophageal squamous cell carcinoma.
Ji Y; Wu XB; Chen JY; Hu B; Zhu QK; Zhu XF; Zheng MF
Int J Clin Exp Med; 2015; 8(8):12850-7. PubMed ID: 26550200
[TBL] [Abstract][Full Text] [Related]
13. Thymidine kinase 1 upregulation is an early event in breast tumor formation.
Alegre MM; Robison RA; O'Neill KL
J Oncol; 2012; 2012():575647. PubMed ID: 22778736
[TBL] [Abstract][Full Text] [Related]
14. Serum thymidine kinase 1 activity in the prognosis and monitoring of chemotherapy in lung cancer patients: a brief report.
Nisman B; Nechushtan H; Biran H; Gantz-Sorotsky H; Peled N; Gronowitz S; Peretz T
J Thorac Oncol; 2014 Oct; 9(10):1568-72. PubMed ID: 25521401
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of equine thymidine kinase 1 and preliminary evaluation of its suitability as a serum biomarker for equine lymphoma.
Wang L; Unger L; Sharif H; Eriksson S; Gerber V; Rönnberg H
BMC Mol Cell Biol; 2021 Dec; 22(1):59. PubMed ID: 34906077
[TBL] [Abstract][Full Text] [Related]
16. The proliferation marker thymidine kinase 1 in clinical use.
Zhou J; He E; Skog S
Mol Clin Oncol; 2013 Jan; 1(1):18-28. PubMed ID: 24649117
[TBL] [Abstract][Full Text] [Related]
17. Cytosolic thymidine kinase is a specific histopathologic tumour marker for breast carcinomas.
He Q; Mao Y; Wu J; Decker C; Merza M; Wang N; Eriksson S; Castro J; Skog S
Int J Oncol; 2004 Oct; 25(4):945-53. PubMed ID: 15375544
[TBL] [Abstract][Full Text] [Related]
18. Can thymidine kinase levels in breast tumors predict disease recurrence?
O'Neill KL; Hoper M; Odling-Smee GW
J Natl Cancer Inst; 1992 Dec; 84(23):1825-8. PubMed ID: 1433372
[TBL] [Abstract][Full Text] [Related]
19. Thymidine kinase 1 is a better prognostic marker than Ki-67 for pT1 adenocarcinoma of the lung.
Xu Y; Liu B; Shi QL; Huang PL; Zhou XJ; Ma HH; Lu ZF; Bo Y; Eriksson S; He E; Skog S
Int J Clin Exp Med; 2014; 7(8):2120-8. PubMed ID: 25232396
[TBL] [Abstract][Full Text] [Related]
20. Serum detection of thymidine kinase 1 as a means of early detection of lung cancer.
Alegre MM; Weyant MJ; Bennett DT; Yu JA; Ramsden MK; Elnaggar A; Robison RA; O'Neill KL
Anticancer Res; 2014 May; 34(5):2145-51. PubMed ID: 24778016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
